Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Aldeyra The

Current price
3.86 USD -0.1 USD (-2.53%)
Last closed 3.98 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 250 307 152 USD
Yield for 12 month -62.16 %
21.11.2021 - 28.11.2021

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases. The company also develops ADX-629, an orally administered RASP modulator for treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa, as well as rare retinal diseases characterized by inflammation and vision loss. In addition, it develops ADX-246 in systemic immune-mediated disease; and ADX-248 in geographic atrophy. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts. Address: 131 Hartwell Avenue, Lexington, MA, United States, 02421

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

9.25 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

+392 620 USD

Last Quarter

Current Year

-262 780 USD

Last Year

-258 707 USD

Current Quarter

+326 151 USD

Last Quarter

-64 999 USD

Key Figures ALDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -42 531 304 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -16.23 %
PEG Ratio
Return On Equity TTM -27.73 %
Wall Street Target Price 9.25 USD
Revenue TTM
Book Value 2.02 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -0.64 USD
Diluted Eps TTM -0.64 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ALDX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ALDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ALDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -3.4975
Price Book MRQ 2.0895

Financials ALDX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ALDX

For 52 weeks

1.42 USD 11.97 USD
50 Day MA 3.51 USD
Shares Short Prior Month 1 828 060
200 Day MA 4.64 USD
Short Ratio 3.86
Shares Short 2 051 607
Short Percent 4.42 %

Dynamics of changes in the value of assets




399.12 USD Microsoft Corporation -4.91 (-1.22%)
Detailed analytics

ETF funds



207.85 CHF iShares MDAX UCITS ETF (DE) 0 (0%)
Detailed analytics



2175.88 USD Gold +5.94 (+0.27%)
Detailed analytics